相关实验视频
Updated: Apr 19, 2026

09:55
In vitro Cell Migration and Invasion Assays
Published on: June 1, 2014
142.2K
一种化学交叉连接的纽丁二聚体结合了具有皮科莫拉亲和力的整体,并抑制了瘤细胞的迁移和增殖
Jun W Kim1, Frank V Cochran, Jennifer R Cochran
1Departments of †Bioengineering and ‡Chemical Engineering, Stanford University , Stanford, California 94305, United States.
Journal of the American Chemical Society
|December 9, 2014
概括
研究人员使用氧化物化学开发了新的二元整合素抑制剂,实现了显著增强的与瘤细胞的结合亲和力. 这种方法对开发更有效的针对血管新生和转移的癌症疗法充满希望.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 综合素alpha-vββ-3 (αvβ3),alpha-vββ-5 (αvβ5),和alpha-5β-1 (α5β1) 是血管生成和转移的关键调节剂.
- 以前通过二元化增强整合素抑制剂疗效的尝试取得了有限的成功.
研究的目的:
- 为了合成和表征具有改善结合亲和力的二元整合素结合小蛋白 (knottins).
- 探索基于氧基的化学结合,以创建具有多种分子拓的纽丁二次体.
主要方法:
- 将含有氨基氧的非天然氨基酸引入结单体.
- 用不同长度的二甲交叉连接器对结丁单体进行化学结合.
- 氧化物结合二聚体与基因融合二聚体和已知的整合素抑制剂 (cilengitide) 的比较.
主要成果:
- 与单体相比,氧化物结合的丁二聚体对瘤细胞的明显结合亲和力显著更高.
- 通过蛋白质中间附近的氨基氧基组进行的二元化比在C端附近更有效;交叉链接器的长度没有影响.
- 最佳的氧基相结合二聚体比单聚体的结合亲和力增加了150倍,在结合和功能抑制方面表现优于西伦吉提德.
结论:
- 以氧化物为基础的化学结合是创建高强度二维整合素抑制剂的关键策略.
- 开发的纽丁二次体显示出优异的瘤细胞结合和抗迁移/增殖效应,这表明其具有治疗潜力.
- 这种方法为癌症治疗的现有整合素向剂提供了一个有希望的替代方案.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
3.9K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.9K
Integrins
6.3K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
6.3K
Activation of Integrins
5.8K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.8K
Cancer Cell Migration through Invadopodia
3.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Inhibition of Cdk Activity
6.3K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K

